Perhaps the most anticipated Q1'23 results of them all.
$Tesla(TSLA.US)$ released its latest results, and it does not look good upfront.
But behind the numbers, perhaps, Tesla is weighing in on a longer-term game plan.
Here are my observations
1. Higher revenue, but deteriorating gross margins
Overall revenue is higher by +24% YoY, but down by -4% QoQ.
As Tesla sought to continue its price cuts, it comes with no surprise that the gross margins will be aff...

2022 benchmark > -18%, Berkshire 4%. 22% lead.
$Berkshire Hathaway 13F(BK2999.US)$ $Berkshire Hathaway-A(BRK.A.US)$ $Berkshire Hathaway-B(BRK.B.US)$ $Apple(AAPL.US)$ $Coca-Cola(KO.US)$

$Helbiz(HLBZ.US)$ i still trust this will BOOM soon

Gainers:
• $Cytokinetics(CYTK.US)$ +8.7% (prices offering of of $450.0 mln of 3.50% convertible senior notes due 2027)
• $XPeng(XPEV.US)$ +3.4% (June deliveries)
• $NIO Inc(NIO.US)$ +2.9% (June deliveries)
• $Bitfarms(BITF.US)$ +2.7% (provides June 2022 production and mining operations update)
• $Accolade(ACCD.US)$ +2.7% (In reaction to earnings/guidance)
• $BioCryst Pharmaceuticals(BCRX.US)$ +2.6% (presents new data demonstrating...